Ulterius Pharmaceuticals Private Limited

Ulterius Pharmaceuticals Private Limited - pharma in Ahmedabad, Gujarat, India. Directors, charges & compliance details.
CIN U24239GJ2020PTC113520 Incorporated 02 May 2020 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2024
₹85.88 Lakh
▼ 32% YoY
Net profit · FY 2024
₹1.26 Lakh
Net margin 1.5%
EBITDA · FY 2024
₹8.22 Lakh
EBITDA margin 9.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Employees · EPFO
3
Provident fund records
Directors on board
4
As per MCA filings

About Ulterius Pharmaceuticals Private Limited

Data last updated:

Ulterius Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 May 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24239GJ2020PTC113520. Its GSTIN is 24AACCU5895L1ZQ (Gujarat).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Devanshi Vijay Thakkar and Bansi Pujara.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 806 Samudra Annexy Nr. Classic Gold Opp. Shantanu Navrangpura, Ahmedabad, Gujarat, India – 380009.

As per the financials filed for FY 2024, the company reported a revenue of ₹85.88 Lakh, a decline of 32% compared to the previous year. For the same year it recorded a net profit of ₹1.26 Lakh (net margin 1.5%) and EBITDA of ₹8.22 Lakh (EBITDA margin 9.6%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years.

The company has about 3 employees on its provident fund (EPFO) records.

Ulterius Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0002000).

Company details

CIN U24239GJ2020PTC113520
Registration Number 113520
Incorporation Date 02 May 2020
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-GJ-01-0002000
Key People
Devanshi Vijay Thakkar Director Bansi Pujara Director Sanjay Muljibhai Thakkar Director

Recognitions & Rankings of Ulterius Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2020-21)
Udyam number
UDYAM-GJ-01-0002000

Contact details

Ulterius Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat.

  • Registered Address
    806 Samudra Annexy Nr. Classic Gold Opp. Shantanu Navrangpura, Ahmedabad, Gujarat, India – 380009
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Ulterius Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Ulterius Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Ulterius Pharmaceuticals Private Limited, buy the company report.

Financials of Ulterius Pharmaceuticals Private Limited

FY 2025 filings available

Ulterius Pharmaceuticals Private Limited reported revenue of ₹85.88 Lakh (down 32% YoY) for FY 2024.

Revenue · FY 2024
₹85.88 Lakh ▼ 32%
Net profit · FY 2024
₹1.26 Lakh margin 1.5%
EBITDA · FY 2024
₹8.22 Lakh margin 9.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 32%
3 years · compounded
▲ 35%
EBITDA CAGR growth
1 year
▲ 224%
3 years · compounded
▲ 67%

Revenue fell 32% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 35%. EBITDA rose 224% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹8.22 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.26 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin9.6%
Net Profit Margin1.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ulterius Pharmaceuticals Private Limited, buy the company report.

Board of directors of Ulterius Pharmaceuticals Private Limited

Ulterius Pharmaceuticals has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Devanshi Vijay ThakkarDirector22 Jul 20206 Years 3 MonthsCurrent
Bansi PujaraDirector30 Jun 20206 Years 4 MonthsCurrent
Sanjay Muljibhai Thakkar
Also directs: Wesgs Milkiaat Private Limited
Director02 May 20206 Years 6 MonthsCurrent
Sangeet Sanjaykumar Thakkar
Also directs: Wesgs Milkiaat Private Limited, Adwait Ayurveda Private Limited
Director02 May 20206 Years 6 MonthsCurrent
View all directors

Peer comparison

Ulterius Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Nurix Pharmaceuticals India Private Limited₹85.91 Lakh (FY 2025)51.0%Pune, Maharashtra, India
Ulterius Pharmaceuticals Private Limitedthis company₹85.88 Lakh (FY 2024)₹1.26 Lakh1.5%-32.0%Ahmedabad, Gujarat, India
Amaruss Pharmaceuticals Private Limited₹85.81 Lakh (FY 2024)-35.0%Kolkata, West Bengal, India
Lorven Pharmaceuticals Private Limited₹85.8 Lakh (FY 2024)93.0%Chennai, Tamil Nadu, India

To see the full peer comparison of Ulterius Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ulterius Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Ulterius Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AACCU5895L1ZQGujaratActive01 Jun 2020

To see the full GST registrations and return filing status of Ulterius Pharmaceuticals Private Limited, buy the company report.

Recent activity

Ulterius Pharmaceuticals Private Limited has 6 board changes on record since 2020: 4 appointments and 2 cessations. The latest: Bansi Pujara ceased to be Additional Director on 30 Nov 2021.

AGM
Ulterius Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ulterius Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Bansi Pujara ceased to be Additional Director.
Ceased
Devanshi Vijay Thakkar ceased to be Additional Director.
Appointed
Devanshi Vijay Thakkar was appointed as Director.
Appointed
Bansi Pujara was appointed as Director.
Appointed
Sangeet Sanjaykumar Thakkar was appointed as Director.
Appointed
Sanjay Muljibhai Thakkar was appointed as Director.
Incorporation
02 May 2020
Ulterius Pharmaceuticals Private Limited was registered on 02 May 2020 with Roc Ahmedabad & aged 6 years 6 months as per MCA records.

Frequently asked questions

Ulterius Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 May 2020 (6+ years old) and is registered under CIN U24239GJ2020PTC113520.

Ulterius Pharmaceuticals has 4 current directors:

The latest financial statements of Ulterius Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Ulterius Pharmaceuticals is 24AACCU5895L1ZQ, registered in Gujarat.

The CIN (Corporate Identification Number) of Ulterius Pharmaceuticals is U24239GJ2020PTC113520. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ulterius Pharmaceuticals was incorporated on 02 May 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.

The peers of Ulterius Pharmaceuticals by revenue are Nurix Pharmaceuticals India Private Limited, Amaruss Pharmaceuticals Private Limited, Lorven Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Bansi Pujara ceased to be Additional Director on 30 Nov 2021. Devanshi Vijay Thakkar ceased to be Additional Director on 30 Nov 2021. Devanshi Vijay Thakkar was appointed as Director on 22 Jul 2020. Ulterius Pharmaceuticals has 6 board changes on record in total.

Yes, Ulterius Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0002000).

The registered office of Ulterius Pharmaceuticals is at 806 Samudra Annexy Nr. Classic Gold Opp. Shantanu Navrangpura, Ahmedabad, Gujarat, India – 380009.

Ulterius Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.